Cargando…

Pharmacokinetics of oral l-serine supplementation in a single patient

Serine, a non-essential amino acid, has attracted clinical attention because of potential benefit in certain metabolic and neurological disorders. Despite the therapeutic potential, little is known about the pharmacokinetics of l-serine metabolism in humans. Here we present pharmacokinetic data at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Danny E., Ferreira, Carlos R., Scott, Anna I., Chang, Irene J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256326/
https://www.ncbi.nlm.nih.gov/pubmed/32489882
http://dx.doi.org/10.1016/j.ymgmr.2020.100607
_version_ 1783539886237679616
author Miller, Danny E.
Ferreira, Carlos R.
Scott, Anna I.
Chang, Irene J.
author_facet Miller, Danny E.
Ferreira, Carlos R.
Scott, Anna I.
Chang, Irene J.
author_sort Miller, Danny E.
collection PubMed
description Serine, a non-essential amino acid, has attracted clinical attention because of potential benefit in certain metabolic and neurological disorders. Despite the therapeutic potential, little is known about the pharmacokinetics of l-serine metabolism in humans. Here we present pharmacokinetic data at the time of treatment initiation as well as plasma serine levels during dose escalation from a single individual taking oral l-serine as part of a treatment regimen. Our results show that plasma serine levels rise and fall rapidly after oral l-serine intake, suggesting that the optimal dosing for oral l-serine supplementation is at least three times per day.
format Online
Article
Text
id pubmed-7256326
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72563262020-06-01 Pharmacokinetics of oral l-serine supplementation in a single patient Miller, Danny E. Ferreira, Carlos R. Scott, Anna I. Chang, Irene J. Mol Genet Metab Rep Short Communication Serine, a non-essential amino acid, has attracted clinical attention because of potential benefit in certain metabolic and neurological disorders. Despite the therapeutic potential, little is known about the pharmacokinetics of l-serine metabolism in humans. Here we present pharmacokinetic data at the time of treatment initiation as well as plasma serine levels during dose escalation from a single individual taking oral l-serine as part of a treatment regimen. Our results show that plasma serine levels rise and fall rapidly after oral l-serine intake, suggesting that the optimal dosing for oral l-serine supplementation is at least three times per day. Elsevier 2020-05-22 /pmc/articles/PMC7256326/ /pubmed/32489882 http://dx.doi.org/10.1016/j.ymgmr.2020.100607 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Miller, Danny E.
Ferreira, Carlos R.
Scott, Anna I.
Chang, Irene J.
Pharmacokinetics of oral l-serine supplementation in a single patient
title Pharmacokinetics of oral l-serine supplementation in a single patient
title_full Pharmacokinetics of oral l-serine supplementation in a single patient
title_fullStr Pharmacokinetics of oral l-serine supplementation in a single patient
title_full_unstemmed Pharmacokinetics of oral l-serine supplementation in a single patient
title_short Pharmacokinetics of oral l-serine supplementation in a single patient
title_sort pharmacokinetics of oral l-serine supplementation in a single patient
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256326/
https://www.ncbi.nlm.nih.gov/pubmed/32489882
http://dx.doi.org/10.1016/j.ymgmr.2020.100607
work_keys_str_mv AT millerdannye pharmacokineticsoforallserinesupplementationinasinglepatient
AT ferreiracarlosr pharmacokineticsoforallserinesupplementationinasinglepatient
AT scottannai pharmacokineticsoforallserinesupplementationinasinglepatient
AT changirenej pharmacokineticsoforallserinesupplementationinasinglepatient